Trials / Recruiting
RecruitingNCT06319300
Artificial Intelligence-assisted Insulin System in Type 2 Diabetes in General Wards
Efficacy and Safety of the Artificial Intelligence-assisted Insulin Dose Adjustment System for Glycaemic Control in Patients With Type 2 Diabetes Mellitus in General Wards: a Multicentre, Single-blind, Randomised Controlled Study
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 140 (estimated)
- Sponsor
- Shanghai Zhongshan Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Our study was a single-blind, randomised, controlled, multicentre study. The study was planned to include 140 patients admitted to the general ward for subcutaneous insulin therapy, who were randomly divided into two groups in the ratio of 1:1, one group with an artificial intelligence assisted insulin dosimetry system to adjust the insulin dose to control their blood glucose, and the other group with a physician instituted insulin dosimetry adjustments to control their blood glucose. The effectiveness and safety of the system was confirmed by comparing the glycaemic control and risk of adverse events between the two groups.
Detailed description
Our study was a single-blind, randomised, controlled, multicentre study. The study was planned to include 140 patients admitted to the general ward for subcutaneous insulin therapy, who were randomly divided into two groups in the ratio of 1:1, one group with an artificial intelligence assisted insulin dosimetry system to adjust the insulin dose to control their blood glucose, and the other group with a physician instituted insulin dosimetry adjustments to control their blood glucose. The effectiveness and safety of the system was confirmed by comparing the glycaemic control and risk of adverse events between the two groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | AI-assisted insulin dose adjustment model | We use an artificial intelligence-assisted insulin dose adjustment system to adjust insulin doses in hospitalised patients |
| OTHER | doctor's insulin dose adjustment | participants' insulin doses are adjusted by doctors |
Timeline
- Start date
- 2024-04-19
- Primary completion
- 2026-03-20
- Completion
- 2026-05-20
- First posted
- 2024-03-20
- Last updated
- 2025-08-06
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06319300. Inclusion in this directory is not an endorsement.